Rodrigo Diaz

TL;DR: In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or hospital discharge were less than 40%.

TL;DR: In this paper, the authors examined patient selection, treatments, outcomes, and ECMO center characteristics over the course of the COVID-19 pandemic to date, and concluded that the role of extracorporeal membrane oxygenation (ECMO) has changed and the use of ECMO has increased.

TL;DR: This document is a consensus of multispecialty international representatives of the Extracorporeal Life Support Organization, including the North America, Latin America, EuroELSO, South West Asia and Africa, and Asia‐Pacific chapters, imparting a global perspective on ECLS.

TL;DR: A complete nomenclature for ECLS cannulation configurations accommodating future revisions was developed to facilitate ability to compare practices and results, to promote efficient communication, and to improve quality of registry data.

TL;DR: In this paper, the authors conducted a population-based study from March 3 to August 31, 2020, using linked data from national agencies to identify the cumulative incidence of extracorporeal membrane oxygenation (ECMO) use in the first pandemic wave and to describe the Nationwide Chilean cohort of ECMO-supported patients with COVID-19.